ABSTRACT
Uncollected filled bins during the COVID pandemic in hospitals and at home are a common issue these days. This becomes a source of community spread of COVID-19. Here the key issue is unsanitary waste management, which can be controlled by an efficient IoT-based smart bin system to present garbage level collected in bins in 'COVID' wards through the use of ultrasonic sensor which stops rubbish from overflowing from smart bins and a gas sensor to determine if any dangerous gases are emitted. The virus and pathogens are neutralized with the help of ultraviolet rays. A rechargeable battery that runs on a solar Piezo hybrid power charges the system. As a result, the bin tends to minimize the potential of infectious illness transmitted to healthcare professionals. Smart bins will prevent overflowing waste from the bins and also stop unsanitary conditions from prevailing nearby. It is a straightforward yet incredibly valuable concept. © 2023 IEEE.
ABSTRACT
OBJECTIVES: Identifying clinical and laboratory indicators that differentiate multisystem inflam-matory syndrome in children (MIS-C) apart from other febrile diseases in a tropical hospital setting. METHOD(S): Review of hospital records done in a tertiary care exclusive children's hospital for children admitted from April, 2020 till June, 2021. Laboratory values, severe acute respiratory syndrome coronavirus (SARS-CoV-2) serological status, and clinical signs and symptoms of patients with MIS-C, and those with similar presentations were analyzed. RESULT(S): 114 children fulfilled the inclusion criteria (age group of 1 mo-18 y) for whom a diagnosis of MIS-C was considered in the emergency room based on the clinical features. Among them, 64 children had the final diagnosis of MIS-C, and the remaining 50 children had confirmatory evidence of infections mimicking MIS-C such as enteric fever, scrub typhus, dengue and appendicitis. CONCLUSION(S): Older age group, presence of muco-cutaneous symptoms, very high C-reactive protein, neutrophilic leukocytosis, abdominal pain and absence of hepatosplenomegaly favor a diagnosis of MIS-C.
ABSTRACT
OBJECTIVE: Identifying clinical and laboratory indicators that differentiate multisystem inflam-matory syndrome in children (MIS-C) apart from other febrile diseases in a tropical hospital setting. METHODS: Review of hospital records done in a tertiary care exclusive children's hospital for children admitted from April, 2020 till June, 2021. Laboratory values, severe acute respiratory syndrome coronavirus (SARS-CoV-2) serological status, and clinical signs and symptoms of patients with MIS-C, and those with similar presentations were analyzed. RESULTS: 114 children fulfilled the inclusion criteria (age group of 1 mo-18 y) for whom a diagnosis of MIS-C was considered in the emergency room based on the clinical features. Among them, 64 children had the final diagnosis of MIS-C, and the remaining 50 children had confirmatory evidence of infections mimicking MIS-C such as enteric fever, scrub typhus, dengue and appendicitis. CONCLUSION: Older age group, presence of muco-cutaneous symptoms, very high C-reactive protein, neutrophilic leukocytosis, abdominal pain and absence of hepatosplenomegaly favor a diagnosis of MIS-C.
Subject(s)
COVID-19 , Child , Humans , Aged , Infant , COVID-19/diagnosis , SARS-CoV-2 , Systemic Inflammatory Response Syndrome/diagnosis , HospitalizationABSTRACT
Background: Corona virus disease has been associated with a wide variety of fungal and bacterial co-infections. These secondary infections could be due to the irrational use of antibiotics, immunosuppressive therapy, pre-existing co morbidities, and immune modulator effects of the virus. But here, we report a very rare occurring of rhino-orbito-cerebral invasive fungal sinusitis in a malnourished child and no other co morbidities. Case presentation: This is a case of a 6-year-old boy with severe thinness and no other co-morbidities, with mild COVID-19 infection, during the course of illness developed rhino-orbito-cerebral invasive fungal sinusitis. The child's mother had COVID-19 1 week prior to child's illness. The child then developed fever followed by headache. The child reported to hospital on seventh day of illness and RTPCR for COVID-19, turned positive. The child's vitals were stable and maintaining saturation. Child was being treated with supplements and symptomatic treatment for fever. On his second day of stay at hospital, he started to develop gradually progressive left-sided peri-orbital swelling. Due to the association of COVID-19 with fungal infection, child was started on AMPHOTERICIN-B and given for 4 days and referred to a higher center for further management. Radiological imaging was suggestive of rhino-sinusitis with orbital cellulitis with meningeal enhancement suggestive of fungal etiology. Debridement was done, child was adequately treated with anti-fungal, and the child showed significant improvement along with radiological clearing. Conclusion: Invasive fungal infection can occur in association with COVID-19 among malnourished pediatric age groups with no other comorbidities.
Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/complications , Humans , Systemic Inflammatory Response SyndromeABSTRACT
Coronavirus causes a wide variety of diseases in various animal species. It is known to cause innocuous respiratory infections and occasional viral diarrhea in humans. Pandemic caused by SARS-CoV-2 (a beta corona virus) is a third spill over in two decades of an animal corona virus to humans. It uses ACE2 receptors for cell entry. Active viral replication has been proved in the cells of human respiratory tract, conjunctiva and gastrointestinal tract contributing to multiple routes of transmission. Peak viral load is noted at the time of presentation which explains the transmission even in presymptomatic stage. RO is expected to be around 2 to 3, which explains the higher pandemic potential. The virus persists on inanimate objects for a variable period of time depending on the infectious dose, temperature and humidity.
ABSTRACT
Background: We describe the demographic, clinical and labo-ratory findings along with the treatment and outcomes among children meeting the case definition of Pediatric Inflammatory Multisystem Syndrome - Temporally associated with SARS-CoV-2 (PIMS-TS). METHODS: We analyzed the clinical and laboratory findings of children who presented with PIMS-TS during an 8-week period from May 4, 2020 to July 8, 2020. RESULTS: We report 19 children with a median age of 6 year (IQR: 13 months-16 years), who met the case definition of PIMS-TS. All of them presented with fever. Multi organ involvement (79%), mucocutaneous involvement (74%), cardiovascular symptoms (63%) and gastrointestinal symptoms (42%) were the other features. Elevated levels of C-reactive protein was found in all of them and the majority of them had evidence of coagulopathy; intensive care admissions were needed in 12 (63%) and vasoactive medications were given to 6 (31.5%) children. There were no deaths. CONCLUSION: Children with PIMS-TS present with a wide range of signs and symptoms. Fewer children in this series had coronary artery abnormalities, and there was a low incidence of RT-PCR positivity with high presence of SARS-CoV-2 antibodies.
Subject(s)
COVID-19/diagnosis , COVID-19/therapy , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/therapy , Adolescent , Antibodies, Monoclonal, Humanized/therapeutic use , Aspirin/therapeutic use , Blood Coagulation Disorders/etiology , C-Reactive Protein/analysis , COVID-19/epidemiology , Child , Child, Preschool , Female , Fever/etiology , Glucocorticoids/therapeutic use , Humans , Immunoglobulins, Intravenous/therapeutic use , India/epidemiology , Infant , Intensive Care Units, Pediatric , International Normalized Ratio , Male , Patient Admission/statistics & numerical data , Platelet Aggregation Inhibitors/therapeutic use , Prothrombin Time , SARS-CoV-2 , Systemic Inflammatory Response Syndrome/epidemiologyABSTRACT
BACKGROUND: We describe the demographic, clinical and laboratory findings along with the treatment and outcomes among children meeting the case definition of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS). METHODS: We analyzed the clinical and laboratory findings of children who presented with PIMS-TS during an 8-week period from May 4, 2020 to July 8, 2020. RESULTS: We report 19 children with a median age of 6 year (IQR: 13 months - 16 years), who met the case definition of PIMS-TS. All of them presented with fever. Multi organ involvement (79%), mucocutaneous involvement (74%), cardiovascular symptoms (63%) and gastrointestinal symptoms (42%) were the other features. Elevated levels of C-reactive protein was found in all of them and the majority of them had evidence of coagulopathy;intensive care admissions were needed in 12 (63%) and vasoactive medications were given to 6 (31.5%) children. There were no deaths. CONCLUSION: Children with PIMS-TS present with a wide range of signs and symptoms. Fewer children in this series had coronary artery abnormalities, and there was a low incidence of RT-PCR positivity with high presence of SARS-CoV-2 antibodies.